Prasugrel Hydrochloride Patent Expiration
Prasugrel Hydrochloride is Used for preventing thrombosis and embolisms in patients at risk of thrombotic cardiovascular events. It was first introduced by Cosette Pharmaceuticals Inc
Prasugrel Hydrochloride Patents
Given below is the list of patents protecting Prasugrel Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Effient |
US8404703 (Pediatric) | Medicinal compositions containing aspirin |
Jul 02, 2023
(Expired) | Cosette |
| Effient |
US8569325 (Pediatric) | Method of treatment with coadministration of aspirin and prasugrel |
Jul 02, 2023
(Expired) | Cosette |
| Effient | US8569325 | Method of treatment with coadministration of aspirin and prasugrel |
Jan 02, 2023
(Expired) | Cosette |
| Effient | US8404703 | Medicinal compositions containing aspirin |
Mar 02, 2022
(Expired) | Cosette |
| Effient | US6693115 | Acid addition salts of hydropyridine derivatives |
Jul 03, 2021
(Expired) | Cosette |
| Effient |
US5288726 (Pediatric) | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation |
Oct 14, 2017
(Expired) | Cosette |
| Effient | US5288726 | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation |
Apr 14, 2017
(Expired) | Cosette |
Prasugrel Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List